This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is most likely a disadvantage of Intensity raising funds through equity ... (Read 125 times)

Jramos095

  • Hero Member
  • *****
  • Posts: 528
Which of the following is most likely a disadvantage of Intensity raising funds through equity financing?
 
  A) Intensity management could lose a controlling interest in the firm.
  B) Intensity would not be able to repay shareholders at any time.
  C) Intensity management would end up in bankruptcy.
  D) Intensity could lose money from currency fluctuations in emerging markets.

Question 2

The gold standard is a ________ because it secured nations' currencies to the value of gold.
 
  A) floating exchange-rate system
  B) fixed exchange-rate system
  C) linked exchange rate system
  D) free float system



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jonathanballen97

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

A

Answer to Question 2

B




Jramos095

  • Member
  • Posts: 528
Reply 2 on: Jul 7, 2018
Wow, this really help


chjcharjto14

  • Member
  • Posts: 342
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library